Hedge Fund - QVT Financial
Halozyme Therapeutics Inc (HALO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2016 - Q2 (2016-06-30) | $4,319,000 | 0.29% | 500,449 | $9.87 |
| 2 | 2016 - Q1 (2016-03-31) | $6,576,000 | 0.4% | 694,436 | $9.41 |
| 3 | 2015 - Q4 (2015-12-31) | $8,427,000 | 0.47% | 486,276 | $15.94 |
| 4 | 2015 - Q3 (2015-09-30) | $6,531,000 | 0.22% | 486,276 | $20.08 |
| 5 | 2015 - Q2 (2015-06-30) | $15,194,000 | 0.22% | 672,883 | $17.58 |
| 6 | 2015 - Q1 (2015-03-31) | $12,157,000 | 0.67% | 851,305 | $14.42 |
| 7 | 2014 - Q4 (2014-12-31) | $19,398,000 | 0.96% | 2,010,186 | $8.88 |
| 8 | 2014 - Q3 (2014-09-30) | $36,906,000 | 1.89% | 4,055,590 | $9.52 |
| 9 | 2014 - Q2 (2014-06-30) | $45,014,000 | 2.43% | 4,556,090 | $8.48 |
| 10 | 2014 - Q1 (2014-03-31) | $53,600,000 | 3.06% | 4,218,800 | $14.84 |
| 11 | 2013 - Q4 (2013-12-31) | $63,240,000 | 3.7% | 4,218,800 | $12.86 |
| 12 | 2013 - Q3 (2013-09-30) | $49,899,000 | 3.39% | 4,519,800 | $8.33 |
| 13 | 2013 - Q2 (2013-06-30) | $36,582,000 | 2.46% | 4,601,500 | $6.37 |
| 14 | 2013 - Q1 (2013-03-31) | $19,750,000 | 1.31% | 3,425,913 | $6.48 |
| 15 | 2012 - Q4 (2012-12-31) | $25,443,000 | 1.69% | 3,791,813 | $5.87 |
| 16 | 2012 - Q3 (2012-09-30) | $24,820,000 | 1.82% | 3,291,813 | $7.14 |
| 17 | 2012 - Q1 (2012-03-31) | $16,692,000 | 1.44% | 1,308,132 | $11.18 |
| 18 | 2011 - Q4 (2011-12-31) | $17,205,000 | 1.38% | 1,809,136 | $8.30 |
| 19 | 2011 - Q3 (2011-09-30) | $13,698,000 | 1.09% | 2,230,938 | $6.59 |
| 20 | 2011 - Q2 (2011-06-30) | $13,163,000 | 0.87% | 1,904,908 | $6.54 |
| 21 | 2011 - Q1 (2011-03-31) | $13,454,000 | 0.8% | 2,112,236 | $6.96 |
| 22 | 2010 - Q4 (2010-12-31) | $15,335,000 | 0.85% | 2,038,174 | $7.53 |
The displayed share prices are average quarterly stock market prices.